The Use of Receptor G-Protein Fusion Proteins for the Study of Ligand Activity

References

• Bahia, D. S., Wise, A., Fanelli, F., Lee, M., Rees, S., and Milligan, G. 1998. Biochemistry 37:11555–11562.
   PubMed Web of Science ®Google Scholar
• Barr, A. J., Brass, L. F., and Manning, D. R. 1997. J. Biol. Chem. 272:2223–2229.
   Google Scholar
• Bertin, B., Friessmuth, M., Jockers, R., Strosberg, A. D., and Marullo, S. 1994. Proc. Natl. Acad. Sci. USA 91:8827–8831.
   PubMed Web of Science ®Google Scholar
• Carr, I. C., Burt, A. R., Jackson, V. N., Wright, J., Wise, A., Rees, S., and Milligan, G. 1998. FEBS Lett. 428:17–22.
   Google Scholar
• Cavalli, A., Druey, K. M., and Milligan, G. 2000. J. Biol. Chem. 275:23693–23699.
   Google Scholar
• De Vries, L., Zheng, B., Fischer, T., Elenko, E., and Farquhar, M. G. 2000. Annu. Rev. Pharmacol. Toxicol. 40:235–271.
   Google Scholar
• Dupuis, D. S., Tardif, S., Wurch, T., Colpaert, F. C., and Pauwels, P. J. 1999. Neuropharmacology 38:1035–1041.
   Google Scholar
• Dupuis, D. S., Wurch, T., Tardif, S., Colpaert, F. C., and Pauwels, P. J. 2001. Neuropharmacology 40:36–47.
   Google Scholar
• Fong, C. W., and Milligan, G. 1999. Biochem. J. 342:457–463.
   Google Scholar
• Hoffmann, M., Ward, R. J., Cavalli, A., Carr, I. C., and Milligan, G. 2001. J. Neurochem. 78:476–485.
   Google Scholar
• Holst, B., Hastrup, H., Raffetseder, U., Martini, L., and Schwartz, T. W. 2001. J. Biol. Chem. 276:19793–19799.
   Google Scholar
• Jackson, V. N., Bahia, D. S., and Milligan, G. 1999. Mol. Pharmacol. 55: 195 – 201.Kellett, E., Carr, I. C., and Milligan, G. 1999. Mol. Pharmacol. 56:684–692.
   Google Scholar
• Loisel, T. P., Ansanay, H., Adam, L., Marullo, S., Seifert, R., Lagace, M., and Bouvier, M. 1999. J. Biol. Chem. 274:31014–31019.
   Google Scholar
• McAllister, G., Stanton, J. A., Salim, K., Handford, E. J., and Beer, M. S. 2000. Mol. Pharmacol. 58:407–412.
   Google Scholar
• Millan,M.J., Cussac,D., Milligan, G.,Carr, C.,Audinot,V.,Gobert, A., Lejeune, F., Rivet, J. M., Brocco, M., Duqueyroix, D., Nicolas, J.-P., Boutin, J., and Newman-Tancredi, A. 2001. J. Pharmacol. Exp. Ther. 297: 876 –887. Milligan, G. 1988. Biochem. J. 255:1–13.
   Google Scholar
• Milligan, G. 2000a. Altering the relative stoichiometry of receptors, G-proteins and effectors: Effectson agonist function. In:The pharmacology of functional, biochemical, and recombinant receptor systems. Handbook of Experimental Pathology, 148, eds. T. Kenakin and J. A. Angus. 363–389. Springer-Verlag: Berlin, Germany.
   Google Scholar
• Milligan, G. 2000b. Trends Pharmacol. Sci. 21:24–28.
   Google Scholar
• Milligan, G. 2002. Methods Enzymol. 343:260–273.
   Google Scholar
• Milligan, G., Kellett, E., Dubreuil, V., Jacoby, E., Dacque, C., and Spedding, M. 2001. Neuropharmacology 40:334–344.
   Google Scholar
• Milligan, G., Marshall, F., and Rees, S. 1996. Trends Pharmacol. Sci. 17:235–237.
   Google Scholar
• Milligan, G., and Rees, S. 1999. Trends Pharmacol. Sci. 20:118–124.
   Google Scholar
• Moon, H. E., Bahia, D. S., Cavalli, A., Hoffman, M., and Milligan, G. 2001. Neuropharmacology 41:321–330.
   Google Scholar
• Moon,H.E., Cavalli, A., Bahia,D.S., Hoffmann, M., Massotte, D.,and Milligan, G. 2001. J. Neurochem. 76:1805–1813.
   Google Scholar
• Newman-Tancredi, A., Audinot, V., Moreira, C., Verriele, L., and Millan, M. 2000. Mol. Pharmacol. 58:1042–1049.
   Google Scholar
• Ostrom, R. S., Post, S. R., and Insel, P. A. 2000. J. Pharmacol. Exp. Ther. 294:407–412.
   PubMed Web of Science ®Google Scholar
• Pauwels, P. J., and Colpaert, F. C. 2000. Br. J. Pharmacol. 130:1505–1512.
   Google Scholar
• Pauwels, P.J., Finana, F., Tardif, S., Colpaert,F. C., and Wurch,T. 2000. Naunyn. Schmiedebergs Arch. Pharmacol. 361:672–679.
   Google Scholar
• Pauwels, P. J., Tardif, S., Finana, F., Wurch, T., and Colpaert, F. C. 2000. J. Neu-rochem. 74:375–384.
   Google Scholar
• Seifert, R., Wenzel-Seifert, K., and Kobilka, B. K. 1999. Trends Pharmacol. Sci. 20: 383 – 387. Seifert, R., Wenzel-Seifert, K., Lee, T. W., Gether, U., Sanders-Bush, E., and Kobilka, B. K. 1998. J. Biol. Chem. 273:5109–5116.
   Google Scholar
• Selbie, L. A., and Hill, S. J. 1988. Trends Pharmacol. Sci. 19:87–93.
   Google Scholar
• Senogles, S. E. 1994. J. Biol. Chem. 269:23120–23127.
   Google Scholar
• Small, K. M., Forbes, S. L., Rahman, F. F., and Liggett, S. B. 2000. Biochemistry 39:2815–2821.
   Google Scholar
• Stevens, P. A., Pediani, J., Carrillo, J. J., and Milligan, G. 2001. J. Biol. Chem. 276:35883–35890.
   Google Scholar
• Tesmer, J. J., Berman, D. M., Gilman, A. G., and Sprang, S. R. 1997. Cell 89:251–261.
   PubMed Web of Science ®Google Scholar
• Unson, C. G., Wu, C.-R., Sakmar, T. P., and Merrifield, R. B. 2000. J. Biol. Chem. 275:21631–21638.
   Google Scholar
• Vorobiov, D., Kanti Bera, A., Keren-Raifman, T., Barzilai, R., and Dascal, N. 2000. J. Biol. Chem. 275:4166–4170.
   Google Scholar
• Waldhoer, M., Wise, A., Milligan, G., Freissmuth, M., and Nanoff, C. 1999. J. Biol. Chem. 274:30571–30579.
   Google Scholar
• Ward, R. J., and Milligan, G. 1999. FEBS Lett. 462:459–463.
   Google Scholar
• Ward, R. J., and Milligan, G. 2002. Cell Signalling 14:139–144.
   Google Scholar
• Wenzel-Seifert, K., Arthur, J. M., Liu, H.-Y., and Seifert, R. 1999. J. Biol. Chem. 274:33259–33266.
   Google Scholar
• Wenzel-Seifert, K., and Seifert, R. 2000. Mol. Pharmacol. 58:954–966.
   Google Scholar
• Wieland, T., and Jakobs, K. H. 1994. Methods Enzymology 237:3–13.
   Google Scholar
• Wise, A., Carr,I.C., Groarke, D.A., and Milligan, G. 1997. FEBS Lett. 419:141–146.
   Google Scholar
• Wise, A., Carr, I. C., and Milligan, G. 1997. Biochem. J. 325:17–21.
   Google Scholar
• Yang, Q., and Lanier, S. M. 1999. Mol. Pharmacol. 56:651–656.
   Google Scholar